Black Rock Inc. Karuna Therapeutics, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$161.01 - $317.85 $8.45 Million - $16.7 Million
52,457 Added 2.67%
2,015,374 $638 Million
Q3 2023

Nov 13, 2023
BUY
$164.66 - $218.08 $16.2 Million - $21.4 Million
98,281 Added 5.27%
1,962,917 $332 Million
Q2 2023

Aug 11, 2023
SELL
$176.32 - $240.22 $107 Million - $145 Million
-605,163 Reduced 24.5%
1,864,636 $404 Million
Q1 2023

May 12, 2023
BUY
$161.33 - $204.36 $10.7 Million - $13.5 Million
66,068 Added 2.75%
2,469,799 $449 Million
Q4 2022

Feb 13, 2023
BUY
$191.53 - $236.82 $28 Million - $34.6 Million
146,037 Added 6.47%
2,403,731 $472 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $45.9 Million - $103 Million
371,050 Added 19.67%
2,257,694 $508 Million
Q2 2022

Aug 12, 2022
BUY
$93.97 - $143.33 $24.5 Million - $37.3 Million
260,239 Added 16.0%
1,886,644 $239 Million
Q1 2022

May 12, 2022
SELL
$98.9 - $132.37 $1.21 Million - $1.62 Million
-12,212 Reduced 0.75%
1,626,405 $206 Million
Q4 2021

Feb 10, 2022
BUY
$110.64 - $159.4 $6.1 Million - $8.79 Million
55,120 Added 3.48%
1,638,617 $215 Million
Q3 2021

Nov 09, 2021
BUY
$101.2 - $125.87 $382,536 - $475,788
3,780 Added 0.24%
1,583,497 $194 Million
Q2 2021

Aug 11, 2021
BUY
$107.45 - $135.95 $170 Million - $215 Million
1,579,717 New
1,579,717 $180 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email